Sernova Biotherapeutics Inc (TSX:SVA)

Sernova Biotherapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 24, 2026	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Market Cap	57	50	81	231	243	326
Market Cap Growth	-10.43%	-38.61%	-64.72%	-5.00%	-25.66%	480.49%
Enterprise Value	61.74	54.44	75.79	210.73	193.03	298.82
Last Close Price	0.17	0.15	0.25	0.76	0.80	1.25
PE Ratio	-	-	2.50	5.85	8.89	41.67
PB Ratio	-2.24	-1.99	-6.28	18.42	5.10	11.63
P/TBV Ratio	-	-	-5.92	18.42	4.60	10.93
P/FCF Ratio	-	-4.58	-4.30	-7.57	-16.45	-47.58
P/OCF Ratio	-	-4.58	-4.30	-7.60	-16.83	-47.70
EV/EBITDA Ratio	-	-3.71	-2.44	-5.26	-7.94	-44.81
EV/EBIT Ratio	-	-3.62	-2.39	-5.20	-7.80	-43.08
EV/FCF Ratio	-	-4.99	-4.01	-6.92	-13.09	-43.55
Debt / Equity Ratio	-0.19	-0.19	-0.04	0	0.00	0.01
Debt / EBITDA Ratio	-0.41	-0.32	-0.02	0.00	-0.01	-0.06
Debt / FCF Ratio	-0.69	-0.44	-0.03	0.00	-0.02	-0.06
Net Debt / Equity Ratio	-0.17	-0.18	0.42	-1.57	-1.04	-0.98
Net Debt / EBITDA Ratio	-0.36	-0.31	0.18	0.49	2.04	4.12
Net Debt / FCF Ratio	-0.61	-0.41	0.29	0.65	3.36	4.01
Quick Ratio	0.03	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.03	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	48.87%	82.79%	14564.17%	-129.73%	-64.54%	-43.25%
Return on Assets (ROA)	-1388.68%	-364.20%	-213.74%	-108.60%	-60.15%	-39.03%
Return on Invested Capital (ROIC)	59.03%	77.50%	247.87%	895.40%	3797.29%	-933.78%
Return on Capital Employed (ROCE)	50.82%	82.27%	-239776.93%	-134.42%	-65.07%	-41.80%
Earnings Yield	-21.58%	0.00%	40.00%	17.11%	11.25%	2.40%
FCF Yield	-	-21.85%	-23.23%	-13.20%	-6.08%	-2.10%
Buyback Yield / Dilution	-2.48%	-0.50%	-6.12%	0.00%	-15.05%	-9.16%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.